One Stop Systems Q2 revenue jumps on higher medical imaging sales; raises 2026 outlook

Second-quarter gross margin was 39.10%, while operating expenses were $11.30 million.

The current average analyst rating on the shares is "buy", with 4 strong buy or buy recommendations, no holds and no sell or strong sell ratings. The median 12-month price target is $19.00, about 33.1% above the August 4 closing price of $14.27.

The stock recently traded at 193 times next 12-month earnings, versus 385 three months ago.

One Stop Systems said second-quarter revenue grew 62% year over year as higher sales to medical imaging, defense and autonomous equipment customers drove the increase.

The U.S. rugged compute provider reported revenue of $9.30 million, compared with the $8.50 million consensus estimate from analysts. Adjusted loss per share was $0.01, beating the $0.02 estimate.